BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29874137)

  • 1. Neurocognitive Outcomes and Interventions in Long-Term Survivors of Childhood Cancer.
    Krull KR; Hardy KK; Kahalley LS; Schuitema I; Kesler SR
    J Clin Oncol; 2018 Jul; 36(21):2181-2189. PubMed ID: 29874137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
    Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
    Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime cohort.
    Phillips NS; Howell CR; Lanctot JQ; Partin RE; Pui CH; Hudson MM; Robison LL; Krull KR; Ness KK
    Cancer; 2020 Feb; 126(3):640-648. PubMed ID: 31631333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.
    Marcoux S; Drouin S; Laverdière C; Alos N; Andelfinger GU; Bertout L; Curnier D; Friedrich MG; Kritikou EA; Lefebvre G; Levy E; Lippé S; Marcil V; Raboisson MJ; Rauch F; Robaey P; Samoilenko M; Séguin C; Sultan S; Krajinovic M; Sinnett D
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27917589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
    Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
    JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive impairment in Asian childhood cancer survivors: a systematic review.
    Peng L; Yam PP; Yang LS; Sato S; Li CK; Cheung YT
    Cancer Metastasis Rev; 2020 Mar; 39(1):27-41. PubMed ID: 31965433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort.
    Tonning Olsson I; Brinkman TM; Hyun G; Banerjee P; Mulrooney DA; Huang IC; Green DM; Srivastava D; Robison LL; Hudson MM; Krull KR
    J Cancer Surviv; 2019 Aug; 13(4):570-579. PubMed ID: 31243647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors.
    Phillips NS; Stratton KL; Williams AM; Ahles T; Ness KK; Cohen HJ; Edelstein K; Yasui Y; Oeffinger K; Chow EJ; Howell RM; Robison LL; Armstrong GT; Leisenring WM; Krull KR
    JAMA Netw Open; 2023 May; 6(5):e2316077. PubMed ID: 37256617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
    Stefanski KJ; Anixt JS; Goodman P; Bowers K; Leisenring W; Scott Baker K; Burns K; Howell R; Davies S; Robison LL; Armstrong GT; Krull KR; Recklitis C
    J Natl Cancer Inst; 2021 Apr; 113(4):481-495. PubMed ID: 32797189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.
    Cheung YT; Brinkman TM; Li C; Mzayek Y; Srivastava D; Ness KK; Patel SK; Howell RM; Oeffinger KC; Robison LL; Armstrong GT; Krull KR
    J Natl Cancer Inst; 2018 Apr; 110(4):411-419. PubMed ID: 29088360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study.
    van der Plas E; Qiu W; Nieman BJ; Yasui Y; Liu Q; Dixon SB; Kadan-Lottick NS; Weldon CB; Weil BR; Jacola LM; Gibson TM; Leisenring W; Oeffinger K; Hudson MM; Robison LL; Armstrong GT; Krull KR
    J Natl Cancer Inst; 2021 May; 113(5):588-596. PubMed ID: 32882041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood.
    Williams AM; Cheung YT; Hyun G; Liu W; Ness KK; Ehrhardt MJ; Mulrooney DA; Bhakta N; Banerjee P; Brinkman TM; Green DM; Chemaitilly W; Huang IC; Srivastava D; Hudson MM; Robison LL; Krull KR
    Ann Neurol; 2021 Mar; 89(3):534-545. PubMed ID: 33274777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.
    Krull KR; Brinkman TM; Li C; Armstrong GT; Ness KK; Srivastava DK; Gurney JG; Kimberg C; Krasin MJ; Pui CH; Robison LL; Hudson MM
    J Clin Oncol; 2013 Dec; 31(35):4407-15. PubMed ID: 24190124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive Outcomes in Children with Brain Tumors.
    Kline CN; Mueller S
    Semin Neurol; 2020 Jun; 40(3):315-321. PubMed ID: 32392601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.